Stock Events

Stock Events

Biosynex 

0
0
+$0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
May 2022
$2.09
May 2021
$0.24
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Oct 20Expected
Q3 2021
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-61.25%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
111.96MRevenue
-68.58MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BSYXF. It's not an investment recommendation.
TotalEnergies
2
TTE.PA
Micron Technology
2
MU
Lvmh Moet Hennessy Louis Vuitton
2
MC.PA
Allianz
2
ALV.F

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories is a direct competitor in the diagnostics and medical devices sector, offering a wide range of products that overlap with Biosynex's offerings in rapid testing and diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories, Inc. competes in the manufacture and distribution of products for the life science research and clinical diagnostics markets, directly overlapping with Biosynex's market.
Danaher
DHR
Mkt Cap150.48B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Biosynex's diagnostics solutions.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with Biosynex's product range.
QuidelOrtho
QDEL
Mkt Cap738.56M
Quidel Corporation specializes in diagnostic healthcare products similar to Biosynex, particularly in the areas of rapid diagnostic testing.
Becton Dickinson
BDX
Mkt Cap48.16B
Becton, Dickinson and Company is a global medical technology company that competes with Biosynex in the development, manufacture, and sale of medical devices, instrument systems, and reagents.
Resmed
RMD
Mkt Cap30.78B
ResMed Inc. operates in the medical equipment and devices sector, offering products that can compete with Biosynex's offerings in certain healthcare and diagnostic applications.
Medtronic
MDT
Mkt Cap110.49B
Medtronic plc specializes in medical technologies, services, and solutions, competing with Biosynex in the broader healthcare and diagnostics market.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation is involved in medical technologies, including surgical equipment and neurovascular products, which indirectly competes with Biosynex by offering alternative medical solutions.

About

Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and point-of-care devices. These offerings are vital for screening, diagnosis, and prevention across numerous medical fields, such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health, alongside specific COVID-19 tests and related instruments. Additionally, Biosynex provides consumer products like self-testing kits, personal health monitoring equipment (including thermometers and blood pressure monitors), and a selection of oral care and medical aid supplies. The company serves a diverse client base, including biological and medical analysis laboratories, hospitals, pharmacies, and large retail outlets like hypermarkets and supermarkets. Founded in 1993, Biosynex S.A. is headquartered in Illkirch-Graffenstaden, France.
Show More
CEO
Employees
397
Country
France
ISIN
FR0011005933
WKN
000A1H8G1

Listings

Grey Market
US
BSYXF
STU
DE
0DL.STU
MU
DE
0DL.MU
F
DE
0DL.F

0 Comments

Share your thoughts

FAQs

What is Biosynex stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Grey Market exchange Biosynex stocks are traded under the ticker BSYXF.
When is the next Biosynex earnings date?▼
Biosynex is going to release the next earnings report on March 3, 2027.
What is Biosynex revenue for the last year?▼
Biosynex revenue for the last year amounts to 111.96M USD.
What is Biosynex net income for the last year?▼
BSYXF net income for the last year is -68.58M USD.
Does Biosynex pay dividends?▼
Yes, BSYXF dividends are paid annual. The last dividend per share was 2.09 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Biosynex have?▼
As of October 25, 2026, the company has 397 employees.
In which sector is Biosynex located?▼
Biosynex operates in the Other sector.
When did Biosynex complete a stock split?▼
The last stock split for Biosynex was on June 19, 2020 with a ratio of 1:1.